Stakes Are High Ahead of FDA Panel Vote on ALS Drug
MONDAY, March 28, 2022 -- Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
The...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news